Shantha Biotechnics delivers 10 million doses of its cholera vaccine
Shantha Biotechnics, an arm of Sanofi Pasteur (the vaccines division of Sanofi), has achieved the milestone of having delivered 10 million doses of its cholera vaccine, Shanchol. The vaccine... Disclosure of Voting results of AGM (Regulation 44(3) of SEBI (LODR) Regulations, 2015)
Sanofi India Ltd has informed BSE regarding the details of Voting results of AGM, under Regulation 44(3) of SEBI (LODR) Regulations, 2015. Kindly Click here Outcome of AGM
Pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 please find enclosed a summary of proceedings of the 61st Annual General Meeting of our Company on 5th May 2017 Scrutinizer's Report
Please find enclosed the Scrutinizer's Report on the e-voting conducted from 2nd May 2017 to 4th May 2017 and polling conducted at the venue of AGM Standalone Financial Results, Limited Review Report for March 31, 2017
Sanofi India Ltd has informed BSE about : 1. Standalone Financial Results for the period ended March 31, 20172. Standalone Limited Review for the period ended March 31, 2017 SES asks Sanofi shareholders to vote against related-party transaction
Resolution will be presented at the AGM tomorrow Apollo Health expects partner Sanofi to help expand diabetes care business
Apollo Health and Lifestyle, the subsidiary of Apollo Hospitals Enterprise Ltd, has said that the the synergy with Sanofi Group in its diabetes care business would help it to grow its presence in India and abroad. The clinical practice model Apollo Sugar Clinics has developed could be expanded across the country and also be scaled up internationally, during when Sanofi's exerience would help it, said Sangita Reddy, joint managing director of AHEL. "As we look to scale and possibly scale internationally with this model, which we believe that it is better most of the models available in the market, I think Sanofi is a very good partner," told Reddy in an interaction with analysts.The company was looking for a partner who had deep understanding of diabetes and Sanofi is one of the leading companies with a large insulin portfolio and with a lot of fundamental research they do in the diabetes space. The company felt that they were a strong strategic partner who help chart out future... Updates
Please find enclosed copies of the Notice of the Board Meeting of the Company published today, in newspapers, Business Standard and Sakal. Board Meeting On May 05, 2017
Pursuant to Regulation 29 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we would like to inform you that the meeting of the Board of Directors of the Company will be held on Friday, 5th May 2017; inter alia to consider the unaudited financial results for the quarter ended March 31, 2017, which is the first quarter of the Company's financial year (Q1). Statement Of Investor Complaints For The Quarter Ended March 2017
Pursuant to Regulation 13(3) of the SEBI (Listing Obligations and Disclosure Requirements), Regulations 2015 please find enclosed statement of investor complaints/grievances for the quarter ended 31st March 2017.